BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3020601)

  • 1. A simple and rapid orientation procedure for the estimation of affinities (1/Kd) and maximum binding capacities (Bmax) of ligand binding to two receptor subpopulations.
    Hynie S; Bojar S; Klenerová V; Wenke M
    Physiol Bohemoslov; 1986; 35(4):299-307. PubMed ID: 3020601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graphical orientation procedure for the estimation of Kd and Bmax values of ligand binding to two receptor subpopulations.
    Hynie S; Klenerová V; Bojar S; Wenke M
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr; 332(4):313-6. PubMed ID: 3016557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-Aminobutyric acid receptor binding in fresh mouse brain membranes at 22 degrees C: ligand-induced changes in affinity.
    Yang JS; Olsen RW
    Mol Pharmacol; 1987 Aug; 32(1):266-77. PubMed ID: 3039341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of ligand binding parameters by simultaneous fitting of association and dissociation data: a Monte Carlo simulation study.
    Karlsson MO; Neil A
    Mol Pharmacol; 1989 Jan; 35(1):59-66. PubMed ID: 2913484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple receptor populations: binding isotherms and their numerical analysis.
    Pliska V
    J Recept Signal Transduct Res; 1995; 15(1-4):651-75. PubMed ID: 8903971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic parameters of ligand-receptor interactions: computation and error margins.
    Pliska V
    J Recept Signal Transduct Res; 1997; 17(1-3):495-510. PubMed ID: 9029510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioligand exchange binding cannot directly determine the dissociation constant (Kd) of the rat ventral prostate nuclear androgen receptor: valid Kd determinations require additional uptake binding data.
    Chapman JC; Freeh SM; Michael SD
    Arch Biochem Biophys; 1993 Dec; 307(2):242-7. PubMed ID: 8274009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacological basis of receptor binding.
    Schütz W
    Wien Klin Wochenschr; 1991; 103(15):438-42. PubMed ID: 1656614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two compartmental models for describing receptor ligand kinetics and receptor availability in multiple injection PET studies.
    Morris ED; Alpert NM; Fischman AJ
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):841-53. PubMed ID: 8784229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretation of binding curves obtained with high receptor concentrations: practical aid for computer analysis.
    Swillens S
    Mol Pharmacol; 1995 Jun; 47(6):1197-203. PubMed ID: 7603460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A theoretical and experimental study of competition between solution and surface receptors for ligand in a Biacore flow cell.
    He X; Coombs D; Myszka DG; Goldstein B
    Bull Math Biol; 2006 Jul; 68(5):1125-50. PubMed ID: 16804651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simple and convenient approach for evaluation of the parameters of ligand-receptor interaction. Receptor blocking index and its application.
    Bobrovnik SA
    J Mol Recognit; 2008; 21(2):96-102. PubMed ID: 18383099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cardiac A1 adenosine receptors by ligand binding and photoaffinity labeling.
    Leung E; Kwatra MM; Hosey MM; Green RD
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1150-6. PubMed ID: 3252029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor.
    Chatterjee TK; Moy JA; Cai JJ; Lee HC; Fisher RA
    Mol Pharmacol; 1993 Feb; 43(2):167-75. PubMed ID: 8381507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concept of reaction volume in the in vivo ligand-receptor model.
    Delforge J; Syrota A; Bendriem B
    J Nucl Med; 1996 Jan; 37(1):118-25. PubMed ID: 8543980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of dissociation constants of inhibitors binding to Src SH2 domain protein by non-covalent electrospray ionization mass spectrometry.
    Bligh SW; Haley T; Lowe PN
    J Mol Recognit; 2003; 16(3):139-48. PubMed ID: 12833569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of gastric mucosal mucin receptor.
    Slomiany BL; Piotrowski J; Czajkowski A; Murty VL; Slomiany A
    Biochem Mol Biol Int; 1993 Nov; 31(4):745-53. PubMed ID: 8298503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
    De Léan A; Ong H; Gutkowska J; Schiller PW; McNicoll N
    Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of agonist and antagonist ligand-binding parameters at the human parathyroid hormone type 1 receptor: evaluation of receptor states and modulation by guanine nucleotide.
    Hoare SR; de Vries G; Usdin TB
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1323-33. PubMed ID: 10336523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.